Total Payments
$7,317
2024 Payments
$1,046
Companies
38
Transactions
198
Medicare Patients
11,460
Medicare Billing
$2.1M
Payment Breakdown by Category
Food & Beverage$5,307 (72.5%)
Travel$1,426 (19.5%)
Education$583.68 (8.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,307 | 184 | 72.5% |
| Travel and Lodging | $1,426 | 7 | 19.5% |
| Education | $583.68 | 7 | 8.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kamada Ltd. | $1,011 | 1 | $0 (2017) |
| Astellas Pharma US Inc | $933.10 | 32 | $0 (2022) |
| COLOPLAST CORP | $886.00 | 17 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $689.44 | 26 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $615.46 | 10 | $0 (2024) |
| Boston Scientific Corporation | $447.48 | 15 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $437.90 | 19 | $0 (2024) |
| ConvaTec Inc. | $272.15 | 6 | $0 (2024) |
| Antares Pharma, Inc. | $212.67 | 10 | $0 (2024) |
| Medtronic USA, Inc. | $149.08 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,046 | 31 | PROCEPT BioRobotics Corporation ($356.02) |
| 2023 | $1,384 | 45 | Myriad Genetic Laboratories, Inc. ($423.03) |
| 2022 | $1,189 | 41 | Astellas Pharma US Inc ($426.35) |
| 2021 | $460.44 | 25 | Astellas Pharma US Inc ($255.28) |
| 2020 | $539.06 | 22 | Coloplast Corp ($122.75) |
| 2019 | $453.14 | 12 | Astellas Pharma US Inc ($169.64) |
| 2018 | $711.36 | 11 | Coloplast Corp ($415.77) |
| 2017 | $1,534 | 11 | Kamada Ltd. ($1,011) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Urology Gynecology | ||||||
| 11/20/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/18/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: UROLOGY | ||||||
| 10/25/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $20.30 | General |
| Category: UROLOGY | ||||||
| 10/16/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $37.81 | General |
| Category: ONCOLOGY | ||||||
| 10/07/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: UROLOGY | ||||||
| 10/04/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $22.58 | General |
| Category: UROLOGY | ||||||
| 09/27/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Men's Health | ||||||
| 09/09/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: UROLOGY | ||||||
| 08/28/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: ONCOLOGY | ||||||
| 08/12/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: UROLOGY | ||||||
| 08/07/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/26/2024 | ConvaTec Inc. | CURE DEXTRA (Device) | Food and Beverage | In-kind items and services | $44.84 | General |
| Category: CONTINENCE CARE | ||||||
| 07/12/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: UROLOGY | ||||||
| 07/03/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $28.40 | General |
| 06/20/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $140.92 | General |
| Category: UROLOGY | ||||||
| 06/20/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $44.34 | General |
| Category: UROLOGY | ||||||
| 06/07/2024 | ConvaTec Inc. | CURE CATHETER (Device) | Food and Beverage | In-kind items and services | $126.33 | General |
| Category: CONTINENCE CARE | ||||||
| 06/06/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $101.19 | General |
| Category: UROLOGY | ||||||
| 05/31/2024 | Olympus America Inc. | iTIND System (Device) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Urology Gynecology | ||||||
| 05/29/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: UROLOGY | ||||||
| 05/07/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Men's Health | ||||||
| 04/16/2024 | 180 Medical, Inc. | GENTLECATH GLIDE (Device) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: CONTINENCE CARE | ||||||
| 04/12/2024 | Endo Pharmaceuticals Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: UROLOGY | ||||||
| 03/29/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $22.81 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,926 | 47,428 | $1.4M | $458,783 |
| 2022 | 25 | 3,959 | 58,683 | $2.3M | $841,980 |
| 2021 | 26 | 3,512 | 13,552 | $1.8M | $661,361 |
| 2020 | 11 | 1,063 | 2,671 | $611,334 | $172,469 |
Total Patients
11,460
Total Services
122,334
Medicare Billing
$2.1M
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2023 | 228 | 3,094 | $210,330 | $106,398 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 335 | 746 | $294,506 | $75,802 | 25.7% |
| 87150 | Identification of organisms by genetic analysis, amplified probe technique | Office | 2023 | 98 | 1,596 | $140,448 | $54,518 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 259 | 664 | $170,845 | $42,340 | 24.8% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2023 | 45 | 47 | $111,992 | $29,573 | 26.4% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2023 | 98 | 399 | $69,825 | $27,267 | 39.1% |
| 87481 | Detection test for candida species (yeast), amplified probe technique | Office | 2023 | 228 | 716 | $58,181 | $24,562 | 42.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 103 | 103 | $53,111 | $13,190 | 24.8% |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | Office | 2023 | 228 | 351 | $28,599 | $12,020 | 42.0% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2023 | 228 | 349 | $26,863 | $11,941 | 44.5% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 59 | 61 | $43,792 | $11,730 | 26.8% |
| 52648 | Complete laser vaporization of prostate including control of bleeding using an endoscope | Facility | 2023 | 15 | 15 | $66,516 | $8,068 | 12.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 36 | 119 | $28,349 | $7,518 | 26.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 61 | $24,393 | $6,365 | 26.1% |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | Office | 2023 | 103 | 141 | $12,265 | $4,788 | 39.0% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2023 | 100 | 137 | $11,985 | $4,650 | 38.8% |
| 87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | Office | 2023 | 98 | 133 | $11,704 | $4,513 | 38.6% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 11 | 24 | $11,004 | $2,837 | 25.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 252 | $18,396 | $2,768 | 15.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 356 | 761 | $8,371 | $2,595 | 31.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 160 | 297 | $11,211 | $2,408 | 21.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $10,982 | $2,158 | 19.7% |
| J1071 | Injection, testosterone cypionate, 1 mg | Office | 2023 | 16 | 37,328 | $9,911 | $772.09 | 7.8% |
| 87150 | Identification of organisms by genetic analysis, amplified probe technique | Office | 2022 | 332 | 8,460 | $744,480 | $291,350 | 39.1% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2022 | 332 | 2,115 | $370,125 | $145,716 | 39.4% |
About Dr. James Stocks, M.D
Dr. James Stocks, M.D is a Urology healthcare provider based in Cypress, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2011. The National Provider Identifier (NPI) number assigned to this provider is 1003197088.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James Stocks, M.D has received a total of $7,317 in payments from pharmaceutical and medical device companies, with $1,046 received in 2024. These payments were reported across 198 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,307).
As a Medicare-enrolled provider, Stocks has provided services to 11,460 Medicare beneficiaries, totaling 122,334 services with total Medicare billing of $2.1M. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Cypress, TX
- Active Since 09/02/2011
- Last Updated 11/28/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003197088
Products in Payments
- ALTIS (Device) $501.24
- XIAFLEX (Biological) $399.84
- AQUABEAM SYSTEM (Device) $356.02
- PROLARIS (Device) $258.12
- MYRBETRIQ (Drug) $237.28
- AQUABEAM ROBOTIC SYSTEM (Device) $211.78
- LITHOVUE (Device) $205.24
- INTERSTIM (Device) $188.13
- CURE CATHETER (Device) $162.52
- Altis (Device) $148.89
- AVEED (Biological) $147.57
- BRACANALYSIS CDX (Device) $119.94
- Axonics (Device) $119.38
- ORENITRAM (Drug) $115.46
- ORGOVYX (Drug) $108.67
- Titan (Device) $108.66
- XYOSTED (Drug) $108.46
- Da Vinci Surgical System (Device) $94.03
- GEMTESA (Drug) $93.79
- BRAC CDx (Device) $81.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.